Trastuzumab-MCC-DM1

ado-trastuzumab emtansine · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Trastuzumab-MCC-DM1, covering 2013-04-23 to 2017-02-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer